You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CLL

Showing 26 - 50 of 1,319
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023

Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Waldenstrom Macroglobulinemia (WM)
  • Shingrix vaccine
  • Rochester, New York
    University of Rochester
Jan 9, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    May 13, 2022

    Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

    Completed
    • Leukemia, Lymphocytic, Chronic
    • Dresden, Germany
    • +10 more
    Jan 13, 2023

    Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Granada, Spain
      • +4 more
      Nov 8, 2023

      Chronic Lymphocytic Leukemia (CLL) Trial (Venetoclax, Rituximab, Ibrutinib)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • (no location specified)
      Apr 2, 2022

      B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
        • Manhasset, New York
          Feinstein Institute for Medical research
        Jul 6, 2022

        Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

        Completed
        • Lymphoid Leukemia
        • +2 more
        • Madison, Wisconsin
          University of Wisconsin
        Jan 30, 2023

        Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)

        Active, not recruiting
        • Chronic Lymphocytic Leucemia
        • Cologne, Germany
          German CLL Study Group
        Apr 29, 2022

        High Risk CLL, Chronic Lymphocytic Leukemia Trial (VenObi+Ven or VenObi+VenZan)

        Not yet recruiting
        • High Risk CLL
        • Chronic Lymphocytic Leukemia
        • VenObi+Ven or VenObi+VenZan
        • (no location specified)
        Jul 26, 2022

        Chronic Lymphocytic Leukemia, CLL Progression, CLL/SLL Trial in New York (Umbralisib, Ublituximab)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +2 more
        • New York, New York
          Weill Cornell Medicine
        Mar 29, 2022

        Chronic Lymphocytic Leukemia Trial in Salt Lake City (Nicotinamide, Placebo)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Salt Lake City, Utah
          Huntsman Cancer Institute at University of Utah
        Jan 17, 2023

        Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

        Not yet recruiting
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • +5 more
        • (no location specified)
        Jul 21, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Biospecimen Collection
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Jan 30, 2023

        Chronic Lymphocytic Leukemia Trial in Houston (Ibrutinib, Venetoclax)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 21, 2022

        Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

        Recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • Basking Ridge, New Jersey
        • +6 more
        Jan 3, 2023

        Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

        Completed
        • CLL
          • Tampere, Finland
            Tampere university Hospital
          Feb 22, 2022

          Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

          Not yet recruiting
          • Leukemia, Lymphocytic, Chronic, B-Cell
          • Zanubrutinib Pill
          • +2 more
          • New York, New York
            Weill Cornell Medicine/NewYork-Presberteryian Hospital
          Dec 6, 2022

          AML Trial in Hangzhou (CLL1 CAR-T)

          Not yet recruiting
          • AML
          • CLL1 CAR-T
          • Hangzhou, China
            The First Affiliated Hospital, Zhejiang University
          Jul 17, 2022

          Relapsed Chronic Lymphocytic Leukemia Trial in Ann Arbor (Metformin)

          Recruiting
          • Relapsed Chronic Lymphocytic Leukemia
          • Ann Arbor, Michigan
            University of Michigan Comprehensive Cancer Center
          May 11, 2022

          CLL, Leukemia Trial in Houston (Eltrombopag)

          Completed
          • CLL
          • Leukemia
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          Mar 14, 2022